News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioElectronics Corporation Continues FDA Clearance Campaign to Bring Chronic Pain Sufferers Safe, Effective, Inexpensive, Drug-Free Pain Therapy


6/11/2013 8:10:42 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

FREDERICK, Md., June 10, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, which has sold 500,000 devices, without prescriptions, in 57 countries reported that they have received three letters from the Office of Science Integrity.  These letters are virtually identical in denying the firm's request for the FDA Commissioner to review her staffs' prior decisions.  Dr. Jesse Goodman, Chief Scientist, said, "I have determined, in my discretion, that additional Agency consideration is not warranted" and simply suggested resubmitting 510(k) premarket notifications or "providing input into the recent CDRH process for reclassification of non-thermal shortwave diathermy devices." 

Andrew Whelan, President of BioElectronics said, "Despite the FDA's egregious delays associated with applications initially filed in 2009, and our primary international business focus, we plan to continue to pursue all possible avenues to get OTC market clearance and bring to American consumers the same safe and affordable pain relief enjoyed by people around the world."

About BioElectronics Corporation

BioElectronics (www.bielcorp.com) is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay Menstrual Cycle Pain Therapy, and RecoveryRx for surgical procedures and wound care.

Contact:

Paul Knopick
940.262.3584
pknopick@eandecommunications.com

SOURCE BioElectronics Corporation



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES